What is a 立入検査 in Japan?

It is an administrative action category used in Japanese public enforcement disclosures. The legal effect depends on the governing statute and issuing authority, so the original Japanese source should be reviewed for the authoritative details.

How should compliance teams use this page?

Use it as an entry point for screening Japanese counterparties by action type, then open the individual record and source announcement before making any onboarding, credit, legal, or procurement decision.

立入検査 Records in Japan

Browse Japanese administrative enforcement records classified as 立入検査. Each record includes the company, governing law, issuing authority, penalty amount when available, and a link to the original Japanese government disclosure.

Useful for long-tail searches such as "立入検査 Japan company", "Japanese administrative 立入検査", and "Japan regulatory sanctions by action type".

3 Japanese enforcement records

Japanese version

Date	Company	Law	Action	Penalty	Authority
4 Sept 2023	株式会社メディファーマ株式会社メディファーマが医療機関から受託した治験業務において、データ改竄等のＧＣＰ違反を確認しました。	医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号）	立入検査	-	Ministry of Health, Labour and Welfare
30 Aug 2023	株式会社メディファーマ株式会社メディファーマが医療機関から受託した治験業務において、データ改竄等のＧＣＰ違反を確認しました。	医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号）	立入検査	-	Ministry of Health, Labour and Welfare
29 Aug 2023	株式会社メディファーマ Medipharm Co., Ltd. was found to have violated GCP in clinical trial operations commissioned from medical institutions, including data falsification.	医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号）	立入検査	-	Ministry of Health, Labour and Welfare

Laws in this set

医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号）3

Issuing authorities

Ministry of Health, Labour and Welfare3

Compliance note

English labels and summaries are provided for search and screening support. The original Japanese government disclosure linked from each record is the authoritative source.